US Stocks
/
BioCardia, Inc. Share Price

BioCardia, Inc. Share Price

NASDAQ: BCDA | Micro Cap
$1.05
-$0.02 (-1.87%) Last updated on 08 Oct, 2026 | 21:39 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

BioCardia, Inc. Stock Performance

Open
$1.07
Prev. Close
$1.07
Circuit Range
N/A
Day Range
$1.05 - $1.08
Year Range
$0.76 - $1.80
Volume
1,600
Average Traded
$1.06

BioCardia, Inc. Share Price Today

As of 9 October 2026, BioCardia, Inc.'s share price is $1.05. The stock opened at $1.07, compared to its previous close of $1.07. During today's trading session, BioCardia, Inc.'s share price traded between $1.05 and $1.08, with an average price of $1.06. Over the past 52 weeks, the stock has recorded a high of $1.80 and a low of $0.76. In terms of performance, BioCardia, Inc.'s share price has declined by 8.70% over the last six months and is down 24.46% on a year-on-year basis.

BioCardia, Inc. Share Price Chart

$1.05$1.08
L
Show Current Price
H

BioCardia, Inc. Stock Fundamentals & Key Indicators

Market Cap
$7.00M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.48
Revenue (TTM)
$0.00
Return On Equity (TTM)
-271.81%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-8.78%

BioCardia, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.48-$1.98-$2.26-$1.61
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-33.78%-14.14%28.76%

BioCardia, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.35$0.48$0.06$0.00
Net Profit-$11.91-$11.57-$7.95-$8.23
Net Profit Margin-882.22%-2410.42%-13250.00%N/A
Income ChangeN/A2.85%31.29%-3.52%

About BioCardia, Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

BioCardia, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.03
$1.05
+1.45%
Sep 2026
$1.11
$1.03
-12.29%
Aug 2026
$0.85
$1.18
+46.40%
Jul 2026
$1.21
$0.81
-35.52%
Jun 2026
$0.90
$1.25
+35.72%
May 2026
$1.13
$0.92
-19.91%
Apr 2026
$1.17
$1.15
-1.29%
Mar 2026
$1.35
$1.17
-10.73%
Feb 2026
$1.12
$1.30
+6.10%
Jan 2026
$1.26
$1.23
-1.60%
Dec 2025
$1.42
$1.25
-12.89%
Nov 2025
$1.41
$1.44
+3.24%

BCDA Share Price FAQs

What is BioCardia, Inc. share price today?

chevron-up
BioCardia, Inc. share price today is $1.05 as on October 8, 2026 at 9:39 pm IST.

What is the 52 week high and 52 week low of BioCardia, Inc. stock?

chevron-up
The 52 week high of BioCardia, Inc. stock is $1.80, while the 52 week low is $0.76 as of 8 Oct '26.

What is BCDA's market capitalisation today?

chevron-up
BCDA market capitalisation is $7.00M as of October 9, 2026, at 4:45 pm IST.

What is BCDA's net income for the last quarter?

chevron-up
BCDA's net income for the last quarter is -1.61B USD.

What is the 5 year returns of BCDA?

chevron-up
The 5 year returns of BCDA is -97.59% as on 8 Oct '26.

What is the high & low stock price of BCDA today?

chevron-up
BCDA stock price hit a high of $1.08 and low of $1.05 as of 8 Oct '26.

Can I buy BCDA shares in India?

chevron-up
Yes. You can buy BCDA in India by opening an international trading account.